The Purpose of This Study is to Determine Whether CerebroFlo™ EVD Catheter is Effective During the Treatment of Intraventricular Hemorrhage (IVH)

Inclusion Criteria:

1. Subject and/or legally authorized representative has reviewed the InstitutionalReview Board (IRB)-approved consent form, has been properly consented per theprotocol and has documented their consent to participate in the study by signing theIRB-approved consent form.

2. Subject is ≥ 18 years of age at the time of consent.

3. Subjects with intraventricular hemorrhage (spontaneous primary IVH or secondary IVHdue to ruptured aneurysm) who have had CerebroFlo™ EVD Catheter(s) placed withoutcomplication.

4. Subjects who require only one EVD Catheter at initial admission

Exclusion Criteria:

1. Subjects with a scalp infection present.

2. Subjects with uncorrectable coagulopathy due to prior administration ofanticoagulants at the time the CerebroFlo™ EVD Catheter(s) is placed.

3. Subjects known to have a bleeding diathesis.

4. Subjects in which the CerebroFlo™ EVD Catheter(s) is placed directly into a hematoma

5. Evidence of catheter-associated hemorrhage from insertion of the CerebroFlo EVDCatheter(s) on post-placement CT scan.

6. Subject is pregnant